Medicare Enrolled
Dr. Ayman Basali, M.D.
Pain Medicine · Wooster, OH
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Basali from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Basali?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Basali
Dr. Ayman Basali is a pain medicine specialist in Wooster, OH, with 20 years of NPI registration. Based on federal Medicare data, Dr. Basali performed 13,266 Medicare services across 2,661 unique beneficiaries.
Between the years covered by Open Payments, Dr. Basali received a total of $5,247 from 43 pharmaceutical and/or device companies across 271 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pain medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Basali is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 2% volume in OH
$5,247 industry payments
Medicare Practice Summary
Medicare Utilization ↗13,266
Medicare services
Top 2% in OH for pain medicine
2,661
Unique beneficiaries
$28
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~663 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
5,182 | $1 | $9 |
| Midazolam injection, per 1 mg Administration of midazolam hydrochloride, a sedative medication, measured in 1 mg increments. |
2,706 | $0 | $17 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,572 | $93 | $186 |
| Ketorolac injection, per 15 mg An injection of ketorolac tromethamine, a nonsteroidal anti-inflammatory drug, administered in doses measured per 15 mg. |
1,060 | $0 | $14 |
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
641 | $0 | $2 |
| Injection into lower spine canal with imaging guidance A procedure where a substance is injected into the lower part of the spinal canal. The injection is performed using imaging guidance to ensure accurate placement. |
362 | $188 | $684 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
313 | $65 | $144 |
| Additional sedation, per 15 minutes Administration of a drug to deepen sedation during a procedure. This code covers each additional 15-minute increment of sedation beyond the initial period. |
212 | $8 | $25 |
| Lactated Ringer's infusion, up to 1000 cc Intravenous administration of Lactated Ringer's solution, a fluid used to replace fluids and electrolytes, in amounts up to 1000 cubic centimeters. |
186 | $2 | $17 |
| Sedation by physician, initial 15 minutes Administration of a drug to induce depression of consciousness by the physician performing a procedure. This code covers the initial 15 minutes of sedation for patients aged 5 years or older. |
149 | $37 | $101 |
| Injection of anesthetic or steroid into sacroiliac joint with imaging guidance This procedure involves injecting an anesthetic or steroid medication into the joint connecting the lower spine and hip bone. Imaging guidance is used to ensure accurate placement of the injection. |
123 | $169 | $1,760 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
106 | $122 | $278 |
| Spinal injection with imaging guidance A procedure where medication is injected into the middle or upper part of the spinal canal. Imaging technology is used to guide the needle to the correct location. |
78 | $188 | $686 |
| Sacral spine nerve root injection with imaging guidance An injection of anesthetic and/or steroid medication into a sacral spine nerve root. The procedure uses imaging guidance to ensure accurate placement. |
78 | $182 | $1,010 |
| Additional sacral spine nerve root injection with imaging An injection of anesthetic and/or steroid medication into an additional sacral spine nerve root level, guided by imaging. |
75 | $84 | $472 |
| Spine facet joint injection with imaging guidance, single level An injection is administered into a single facet joint of the lower or sacral spine while using imaging guidance to ensure accurate placement. |
75 | $179 | $1,448 |
| Facet joint injection, second level, with imaging guidance An injection into a lower or sacral spine facet joint using imaging guidance for the second level treated. |
75 | $94 | $661 |
| Spine facet joint injection with imaging guidance, single level An injection is administered into a single facet joint of the upper or middle spine while using imaging guidance to ensure accurate placement. |
54 | $178 | $1,425 |
| Facet joint injection, second level, with imaging An injection into a second spinal facet joint in the upper or middle spine, guided by imaging to ensure accurate placement. |
54 | $90 | $600 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
50 | $53 | $238 |
| Spinal or brain drug pump maintenance A healthcare professional performs maintenance on a drug infusion pump implanted in the spinal canal or brain. |
40 | $63 | $250 |
| Fluoroscopic guidance for needle placement Use of real-time X-ray imaging to guide the precise placement of a needle during a medical procedure. |
28 | $83 | $197 |
| Facet joint nerve destruction, single joint A procedure to destroy nerves in a single lower or sacral spinal facet joint using imaging guidance to target pain signals. |
17 | $329 | $1,150 |
| Facet joint nerve destruction, additional joint This procedure uses imaging guidance to destroy nerves in an additional lower or sacral spinal facet joint. |
17 | $179 | $465 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
13 | $9 | $44 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.4% high complexity
80.1% medium
18.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$5,247
Total received (2018-2024)
Avg $750/year across 7 years
Top 29% in OH for pain medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
43
Companies
271
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,247 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$938
2023
$360
2022
$521
2021
$1,408
2020
$269
2019
$900
2018
$851
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Medtronic, Inc.
$201
Forte Bio-Pharma LLC
$182
Abbott Laboratories
$163
Collegium Pharmaceutical, Inc.
$106
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$52
Amgen Inc.
$52
Nevro Corp.
$40
Averitas Pharma Inc.
$30
Boston Scientific Corporation
$26
VERTEX PHARMACEUTICALS INCORPORATED
$22
Nalu Medical, Inc.
$20
Saluda Medical Americas, Inc.
$16
Stryker Corporation
$15
PAINTEQ LLC
$14
Top 3 companies account for 58.2% of 2024 payments
All-time payments by company (2018-2024) ›
Collegium Pharmaceutical, Inc.
$1,031
Genesys Orthopedics Systems, L.L.C.
$803
Abbott Laboratories
$439
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$306
Amgen Inc.
$283
Scilex Pharmaceuticals Inc.
$248
Medtronic, Inc.
$247
Forte Bio-Pharma LLC
$182
BioDelivery Sciences International, Inc.
$165
Flowonix Medical Incorporated
$155
Novartis Pharmaceuticals Corporation
$146
Nevro Corp.
$133
Stimwave Technologies Incorporated
$115
Daiichi Sankyo Inc.
$105
INSYS Therapeutics Inc
$90
Organogenesis Inc.
$88
BIODELIVERY SCIENCES INTERNATIONAL, INC.
$79
BIOTRONIK INC.
$75
PFIZER INC.
$66
Kowa Pharmaceuticals America, Inc.
$38
Horizon Therapeutics plc
$34
Nuvectra Corporation
$31
Averitas Pharma Inc.
$30
Almatica Pharma LLC
$30
BOSTON SCIENTIFIC CORPORATION
$30
Boston Scientific Corporation
$26
Assertio Therapeutics, Inc.
$23
VERTEX PHARMACEUTICALS INCORPORATED
$22
Medtronic USA, Inc.
$20
Nalu Medical, Inc.
$20
SCILEX PHARMACEUTICALS INC.
$19
Shionogi Inc
$19
Saluda Medical Americas, Inc.
$16
Zyla Life Sciences
$16
SI-BONE, INC.
$16
Stryker Corporation
$15
Purdue Pharma L.P.
$14
PAINTEQ LLC
$14
Lilly USA, LLC
$13
AstraZeneca Pharmaceuticals LP
$12
ASSERTIO THERAPEUTICS, Inc.
$12
DePuy Synthes Sales Inc.
$12
Teva Pharmaceuticals USA, Inc.
$12
Top 3 companies account for 43.3% of all-time payments
Associated products mentioned in payments ›
AIMOVIG · AJOVY · Affinity/NuShield/Puraply · Aimovig · Algovita · BELBUCA · BUNAVAIL 2.1 mg 30-count box · Belbuca · DUEXIS · EMGALITY · ETERNA · EVENITY · Evoke · GENERAL PAIN MANAGEMENT · Gralise · IFUSE IMPLANT · INTELLIS ADAPTIVESTIM · KRYSTEXXA · LUCEMYRA · LYRICA · MONOVISC · MOVANTIK · MYSTIM · Morphabond ER · NALOCET · NAPRELAN · Nalu Neurostimulation System · Nucynta ER · PAINTEQ · PROCLAIM · PROLATE · Proclaim Family of SCS IPGs · Proclaim IPG · Prodigy Family of SCS IPGs · Prometra II · QUTENZA · RELISTOR · SACROILIAC JOINT FUSION SYSTEM · SEGLENTIS · SPINEJACK · SUBSYS · SYMPROIC · SYNDROS · Seglentis · Senza · Senza Spinal Cord Stimulation System · Symproic · VIMOVO · XTAMPZA · XTAMPZAER · Xtampza ER · XtampzaER · ZORVOLEX · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Pain medicines within 10 mi
3
Per 100K population
2.6
County median income
$71,769
Nearest hospital
WOOSTER COMMUNITY HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Basali is a clinical cardiology specialist, with above-average Medicare volume (top 2% in OH), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Basali experienced with steroid injection (triamcinolone)?
Based on Medicare claims data, Dr. Basali performed 5,182 steroid injection (triamcinolone) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Basali receive payments from pharmaceutical companies?
Yes. Dr. Basali received a total of $5,247 from 43 companies across 271 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Basali's costs compare to other pain medicines in Wooster?
Dr. Basali's average Medicare payment per service is $28. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Basali) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Pain Medicines in Wooster
Browse pain medicines in Wooster ranked by procedure volume and transparency data.
Highest volume
Top Pain Medicines in OH
Pain medicines ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pain Medicines in OH
Which OH pain medicines receive the most from drug and device companies.
By company
Collegium Pharmaceutical, Inc. Payments to Doctors
See all physicians who received payments from Collegium Pharmaceutical, Inc.
By company
Genesys Orthopedics Systems, L.L.C. Payments to Doctors
See all physicians who received payments from Genesys Orthopedics Systems, L.L.C.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology